FDG PET/CT Findings in Abdominal Fat Necrosis After Treatment for Lymphoma. (May 2016)

• Record Type: Journal Article
• Authors: Dubreuil, Julien; Moreau, Aurélie; Sarkozy, Clémentine; Traverse-Glehen, Alexandra; Skanjeti, Andrea; Salles, Gilles; Giammarile, Francesco
• Is Part Of: Clinical nuclear medicine. Volume 41:Number 5(2016)
• Publication Date: 2016-05
• Subjects: fat necrosis -- evaluation -- lymphoma -- FDG PET/CT; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000001111
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract : Abstract: FDG PET/CT is now validated in non-Hodgkin lymphoma for response assessment in interim and posttreatment lymphoma. We report the case of a 62-year-old man followed by FDG PET/CT for a diffuse large B-cell lymphoma, with initial stage III. The interim FDG PET/CT examination concluded in complete metabolic and morphological response of subdiaphragmatic lymphadenopathy but a persistent abnormal subdiaphragmatic uptake (SUVmax at 9 and Deauville 5-point scale at 5). Therefore, an abdominal biopsy of the corresponding nodules was conducted with a final diagnosis of diffuse fat necrosis.